Role of microRNA-182 in posterior uveal melanoma: Regulation of tumor development through MITF, BCL2 and cyclin D2

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Yan, Dongsheng ^a,b   da Dong, Xiang ^c   Chen, Xiaoyan ^a,b   Yao, Shasha ^a,b   Wang, Lihua ^a,b   Wang, Jiao ^a,b   Wang, Chao ^a,b   Hu, Dan Ning ^b,d   Qu, Jia ^a,b   Tu, LiLi ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b State Key Laboratory Cultivation Base and Key Laboratory of Vision Science   (China)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYCLIN D2; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICRORNA 182; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MET; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UVEA MELANOMA; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CYCLIN D2; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEIN P53; UVEAL NEOPLASMS;

EID: 84864403076     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040967     Document Type: Article

References (43)

1. Kincaid MC,((1998)) Uveal Melanoma. Cancer Control 5:: 299--309.
2. Hurst EA, Harbour JW, Cornelius LA,((2003)) Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol 139:: 1067--1073.
3. Henriquez F, Janssen C, Kemp EG, Roberts F,((2007)) The T1799A BRAF mutation is present in iris melanoma. Invest Ophthalmol Vis Sci 48:: 4897--4900.
4. Malaponte G, Libra M, Gangemi P, Bevelacqua V, Mangano K, et al.((2006)) Detection of BRAF gene mutation in primary choroidal melanoma tissue. Cancer Biol Ther 5:: 225--227.
5. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, et al.((2009)) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457:: 599--602.
6. Bakalian S, Marshall JC, Logan P, Faingold D, Maloney S, et al.((2008)) Molecular pathways mediating liver metastasis in patients with uveal melanoma. Clin Cancer Res 14:: 951--956.
7. Levy C, Khaled M, Fisher DE,((2006)) MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12:: 406--414.
8. Steingrimsson E, Copeland NG, Jenkins NA,((2004)) Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38:: 365--411.
9. Miller AJ, Du J, Rowan S, Hershey CL, Widlund HR, et al.((2004)) Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res 64:: 509--516.
10. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, et al.((2009)) Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 106:: 1814--1819.
11. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, et al.((2006)) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20:: 3426--3439.
12. Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, et al.((2004)) V599EB-RAF is an oncogene in melanocytes. Cancer Res 64:: 2338--2342.
13. Wellbrock C, Rana S, Paterson H, Pickersgill H, Brummelkamp T, et al.((2008)) Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One 3:: e2734.
14. Yan D, Zhou X, Chen X, Hu DN, Dong XD, et al.((2009)) MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 50:: 1559--1565.
15. Lee RC, Feinbaum RL, Ambros V,((1993)) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:: 843--854.
16. Kozomara A, Griffiths-Jones S,((2011)) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:: D152--157.
17. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al.((2005)) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:: 13944--13949.
18. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, et al.((2007)) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17:: 1298--1307.
19. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al.((2007)) A microRNA component of the p53 tumour suppressor network. Nature 447:: 1130--1134.
20. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, et al.((2007)) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6:: 1586--1593.
21. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, et al.((2007)) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:: 745--752.
22. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D,((1998)) Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 58:: 2170--2175.
23. Lin WM, Baker AC, Beroukhim R, Winckler W, Feng W, et al.((2008)) Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 68:: 664--673.
24. Xu S, Witmer PD, Lumayag S, Kovacs B, Valle D,((2007)) MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem 282:: 25053--25066.
25. Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, et al.((2004)) Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA 101:: 10608--10613.
26. Worley LA, Long MD, Onken MD, Harbour JW,((2008)) Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res 18:: 184--190.
27. Lekmine F, Chang CK, Sethakorn N, Das Gupta TK, Salti GI,((2007)) Role of microphthalmia transcription factor (Mitf) in melanoma differentiation. Biochem Biophys Res Commun 354:: 830--835.
28. Salti GI, Manougian T, Farolan M, Shilkaitis A, Majumdar D, et al.((2000)) Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Cancer Res 60:: 5012--5016.
29. Selzer E, Wacheck V, Lucas T, Heere-Ress E, Wu M, et al.((2002)) The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Cancer Res 62:: 2098--2103.
30. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M,((2008)) MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 18:: 549--557.
31. Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, et al.((2010)) MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 130:: 2062--2070.
32. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, et al.((2005)) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436:: 117--122.
33. Mouriaux F, Vincent S, Kherrouche Z, Maurage CA, Planque N, et al.((2003)) Microphthalmia transcription factor analysis in posterior uveal melanomas. Exp Eye Res 76:: 653--661.
34. Chen X, Wang J, Shen H, Lu J, Li C, et al.((2010)) Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Invest Ophthalmol Vis Sci 52:: 1193--1199.
35. McGill GG, Haq R, Nishimura EK, Fisher DE,((2006)) c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem 281:: 10365--10373.
36. Puri N, Ahmed S, Janamanchi V, Tretiakova M, Zumba O, et al.((2007)) c-Met is a potentially new therapeutic target for treatment of human melanoma. Clin Cancer Res 13:: 2246--2253.
37. Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, et al.((1998)) c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 58:: 5157--5167.
38. Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, et al.((2004)) Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 6:: 565--576.
39. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, et al.((2002)) Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109:: 707--718.
40. Soulieres D, Rousseau A, Deschenes J, Tremblay M, Tardif M, et al.((1991)) Characterization of gangliosides in human uveal melanoma cells. Int J Cancer 49:: 498--503.
41. Livak KJ, Schmittgen TD,((2001)) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:: 402--408.
42. Naito S, von Eschenbach AC, Giavazzi R, Fidler IJ,((1986)) Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res 46:: 4109--4115.
43. Hoefig KP, Heissmeyer V,((2010)) Measuring microRNA expression in size-limited FACS-sorted and microdissected samples. Methods Mol Biol 667:: 47--63.